Abstract:Hypoxia-ischemia is the most common cause of neonatal encephalopathy (NE). In most cases, an intrapartum event is presumed to lead to perinatal hypoxia ischemia, but the exact pathogenesis, and therefore timing, are often not known. 1 In well-resourced settings, therapeutic hypothermia (TH) reduces death and major neurodevelopmental disability in infants with NE. 2 However, there is heterogeneity in outcomes, and major neurodevelopmental disability is still seen in about one third of survivors who are treated with therapeutic hypothermia. 3 The heterogeneity in response of NE to TH means alternative treatments are desperately sought. As such, many biomarkers have been studied as surrogate measures of long-term outcome, in order to expedite assessment of potential treatments. Moreover, an important goal is to personalize treatment for NE such that individuals who might benefit from a different approach to TH, might be detected early. It is also important to study biomarkers that can discriminate between which babies benefit from TH versus those who may be at higher risk of an adverse outcome. 4 In the study by O'Gorman Tuura et al., the authors have explored the link between perfusion and neurodevelopmental outcomes using arterial spine labeling (ASL) as a neuroimaging marker for outcome prediction. 5 ASL is a noninvasive magnetic resonance imaging (MRI) technique in which protons in blood and water are magnetically labeled and the signal generated by the endogenous labels are detected by subtracting MRI signals during alternating labeled and unlabeled acquisitions. The images demonstrate signal intensity proportional to the amount of perfusion in each voxel and a quantitative measurement of cerebral blood flow (CBF) can be calculated. 6 Previous authors have described patterns of CBF using ASL in NE. Wintermark et al. demonstrated initial hypoperfusion on day 1 followed by hyperperfusion at days 2–3. 7 A study by Tang et al. reported lower CBF values in neonates with NE at 0–24 h and 3–7 days with higher values in the 1–3 day-old group. 8 The mean age at MRI in O'Gorman Tuura's paper was 5 days (range 3–9 days), which means that any hyperperfusion identified may not represent the 'peak' perfusion phase, but rather the tail end of the more severe cases. The problem with that theory is that the cohort studied included infants with mild to moderate NE and the authors found a relationship between altered perfusion and outcome even in those children with mild to moderate impairment following NE.

Diagnostic Performance of Arterial Spin-Labeled Perfusion Imaging and Diffusion-Weighted Imaging in Full-Term Neonatal Hypoxic-Ischemic Encephalopathy

Application of MR ASL perfusion weighted imaging in the diagnosis of full-term neonatal hypoxic ischemic encephalopathy

Application of 3.0T MR Arterial Spin Labeling and Diffusion Weighted Imaging in Full-Term Neonatal Hypoxic Ischemic Encephalopathy

Microstructural Alterations in Projection and Association Fibers in Neonatal Hypoxia-Ischemia.

Investigate the value of diffusion weighted MRI and proton MRS in early diagnosing hypoxic-ischemic encephalopathy in full-term infants

Study on the Application of Diffusion Weighted Imaging in Evaluation of Hypoxic-ischemic Encepha-lopathy in Neonates

Cerebral blood flow in neonatal encephalopathy: biomarker or potential target?

Application value of three-dimensional arterial spin labeling perfusion imaging in investigating cerebral blood flow dynamics in normal full-term neonates

Neonatal hypoxic-ischemic encephalopathy:detection with diffusion-weighted and diffusion-tensor MR imaging

Diffusion Tensor Imaging Assesses White Matter Injury in Neonates with Hypoxic-Ischemic Encephalopathy.

Applied Value of Diffusion Tensor Imaging in Early Evaluation of Prognosis of Hypoxic-Ischemic Encephalopathy in New Infants

Changes of cerebral blood flow in neonates with hypoxic ischemic en-cephalopathy and the clinical value of prognostic evaluation of prognosis

Amide Proton Transfer and Apparent Diffusion Coefficient Analysis Reveal Susceptibility of Brain Regions to Neonatal Hypoxic-Ischemic Encephalopathy

Feasibility of Oscillating and Pulsed Gradient Diffusion MRI to Assess Neonatal Hypoxia-Ischemia on Clinical Systems.

The Role of ADC Values in Evaluating Follow-Up Value of Neonatal Hypoxic-Ischemic Encephalopathy: Initial Experience

Magnetic resonance imaging scanning susceptibility weighted imaging sequences in the diagnosis and prognostic evaluation of neonatal hypoxic-ischemic encephalopathy

Application of Color Doppler Ultrasonography by Bed Side in the Early Diagnosis of Hypoxic-Ischemic Encephalopathy in Full Term Neonates

FA VALUES IN EVALUATING MYELINATION OF NEONATAL HYPOXIC-ISCHEMIC ENCEPHALOPATHY

Comparison of Chemical Exchange Saturation Transfer Imaging with Diffusion-weighted Imaging and Magnetic Resonance Spectroscopy in a Rat Model of Hypoxic-ischemic Encephalopathy

Transcranial Doppler Ultrasonography detection on cerebrovascular flow for evaluating neonatal hypoxic-ischemic encephalopathy modeling

Diagnostic value of the signal intensity on T1 -weighted images of MRI and 1H MRS for neonatal hypoxic-ischemic encephalopathy